Aerosol Valves Market Size, Share & Trends Analysis Report By Product (Continuous, Metered), By Application (Personal Care, Household, Automotive & Industrial, Foods, Paints, Medical), By Region, And Segment Forecasts, 2025 - 2030
Aerosol Valves Market Growth & Trends
The global aerosol valves market size is estimated to reach USD 24.01 billion by 2030, expanding at a CAGR of 6.6% from 2025 to 2030, according to a new report by Grand View Research, Inc. Increasing product penetration in the healthcare industry for products, such as asthma inhalers and other types of sprays, is expected to boost the demand over the forecast period. Growing consumption of personal care and household products in various countries is also anticipated to drive the product demand. In addition, the introduction of innovative personal care and household products by FMCG manufacturers, such as P&G, is expected to augment the demand for aerosol components including valves.
The components used for the manufacturing of aerosol valves, such as gaskets, seals, springs, and dip tubes, are available in abundance owing to the presence of a large number of manufacturers. In addition, low product differentiation enables easy supplier switching at a low cost. The combined effect of this has resulted in low bargaining power of suppliers. Companies in the industry are focusing on product innovation for the development of eco-friendly components using latest aerosol technologies. Over the past few years, there has been a shift from traditional manufacturing to enhanced sustainability, which includes reduced use of energy and raw materials.
Aerosol Valves Market Report Highlights
- The other products segment dominated the overall market with a revenue share of over 59.0% in 2024 and is expected to witness robust growth with a CAGR of 6.8% over the forecast period.
- Metered aerosol valves are designed to deliver a specific, pre-measured dose of the product with each press of the actuator. owing to the increase in demand for consumer products such as household cleaners, and automotive products.
- The personal care segment held the largest revenue share of 33.0% in 2024. The segment is driven by the growing demand for personal care products in emerging economies owing to the changing lifestyle, rising consumer spending, and emphasis on gender-specific products.
- Europe dominated the market and accounted for the largest revenue share of 27.0% in 2024. Continuous technological improvement in aerosol valve design has led to the development of more efficient aerosol valves.
- In North America, the pharmaceutical and healthcare sector has also been a crucial driver for aerosol valve demand.
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.1.1. Type Segment
- 1.1.2. End Use Segment
- 1.2. Regional Scope
- 1.3. Estimates and Forecast Timeline
- 1.4. Research Methodology
- 1.5. Information Procurement
- 1.5.1. Purchased Database
- 1.5.2. GVR’s Internal Database
- 1.5.3. Primary Research
- 1.6. Information or Data Analysis:
- 1.6.1. Data Analysis Models
- 1.7. Market Formulation & Validation
- 1.8. Model Details
- 1.8.1. Commodity Flow Analysis
- 1.9. List of Secondary Sources
- 1.10. List of Abbreviations
- 1.11. Objective
- Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
- Chapter 3. Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Increase in adoption of next-generation sequencing
- 3.2.1.2. Growing R&D in proteomics and genomics
- 3.2.1.3. Presence of an extensive drug-development pipeline
- 3.2.1.4. Increasing adoption of personalized medicine
- 3.2.1.5. Rapid technological advances in biochip technology
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. High cost of manufacturing
- 3.3. Industry Analysis Tools
- 3.3.1. Porter’s Five Forces Analysis
- 3.3.2. PESTEL Analysis
- 3.3.3. COVID-19 Impact Analysis
- Chapter 4. Type Group Business Analysis
- 4.1. Type Segment Dashboard
- 4.2. Biochip Market Type Movement Analysis
- 4.3. Biochip Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
- 4.4. DNA Chips
- 4.4.1. DNA chips market estimates and forecasts, 2018 - 2030 (USD Million)
- 4.4.2. Cancer Diagnosis and Treatment
- 4.4.2.1. Cancer diagnosis and treatment market estimates and forecasts, 2018 - 2030 (USD Million)
- 4.4.3. Gene Expression
- 4.4.3.1. Gene expression market estimates and forecasts, 2018 - 2030 (USD Million)
- 4.4.4. SNP Genotyping
- 4.4.4.1. SNP genotyping market estimates and forecasts, 2018 - 2030 (USD Million)
- 4.4.5. Genomics
- 4.4.5.1. Genomics market estimates and forecasts, 2018 - 2030 (USD Million)
- 4.4.6. Drug Discovery
- 4.4.6.1. Drug discovery market estimates and forecasts, 2018 - 2030 (USD Million)
- 4.4.7. Agricultural Biotechnology
- 4.4.7.1. Agricultural biotechnology market estimates and forecasts, 2018 - 2030 (USD Million)
- 4.4.8. Others
- 4.4.8.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)
- 4.5. Protein Chips
- 4.5.1. Protein chips market estimates and forecasts, 2018 - 2030 (USD Million)
- 4.5.2. Proteomics
- 4.5.2.1. Proteomics market estimates and forecasts, 2018 - 2030 (USD Million)
- 4.5.3. Expression Profiling
- 4.5.3.1. Expression profiling market estimates and forecasts, 2018 - 2030 (USD Million)
- 4.5.4. Diagnostics
- 4.5.4.1. Diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
- 4.5.5. HTS
- 4.5.5.1. HTS market estimates and forecasts, 2018 - 2030 (USD Million)
- 4.5.6. Drug Discovery
- 4.5.6.1. Drug discovery market estimates and forecasts, 2018 - 2030 (USD Million)
- 4.5.7. Others
- 4.5.7.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)
- 4.6. Lab-on-chip
- 4.6.1. Lab-on-chip market estimates and forecasts, 2018 - 2030 (USD Million)
- 4.6.2. Genomics
- 4.6.2.1. Genomics market estimates and forecasts, 2018 - 2030 (USD Million)
- 4.6.3. IVD & POC
- 4.6.3.1. IVD & POC market estimates and forecasts, 2018 - 2030 (USD Million)
- 4.6.4. Proteomics
- 4.6.4.1. Proteomics market estimates and forecasts, 2018 - 2030 (USD Million)
- 4.6.5. Drug Discovery
- 4.6.5.1. Drug discovery market estimates and forecasts, 2018 - 2030 (USD Million)
- 4.6.6. Others
- 4.6.6.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)
- 4.7. Tissue Arrays
- 4.7.1. Tissue arrays market estimates and forecasts, 2018 - 2030 (USD Million)
- 4.8. Cell Arrays
- 4.8.1. Cell arrays market estimates and forecasts, 2018 - 2030 (USD Million)
- Chapter 5. End Use Business Analysis
- 5.1. End Use Segment Dashboard
- 5.2. Biochip Market End Use Movement Analysis
- 5.3. Biochip Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
- 5.4. Biotechnology & Pharmaceutical Companies
- 5.4.1. Biotechnology & pharmaceutical companies market estimates and forecasts, 2018 - 2030 (USD Million)
- 5.5. Hospitals & Diagnostic Centers
- 5.5.1. Hospitals & diagnostic centers market estimates and forecasts, 2018 - 2030 (USD Million)
- 5.6. Academic & Research Institute
- 5.6.1. Academic & research institute market estimates and forecasts, 2018 - 2030 (USD Million)
- 5.7. Others
- 5.7.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)
- Chapter 6. Regional Business Analysis by Type, End Use
- 6.1. Regional Dashboard
- 6.2. Market Size & Forecast and Trend Analysis, 2024 & 2030
- 6.3. North America
- 6.3.1. North America Biochip Market, 2018 - 2030 (USD Million)
- 6.3.2. U.S.
- 6.3.2.1. Key Country Dynamics
- 6.3.2.2. Competitive Scenario
- 6.3.2.3. Target Disease Prevalence
- 6.3.2.4. U.S. Biochip Market, 2018 - 2030 (USD Million)
- 6.3.3. Canada
- 6.3.3.1. Key Country Dynamics
- 6.3.3.2. Competitive Scenario
- 6.3.3.3. Target Disease Prevalence
- 6.3.3.4. Canada Biochip Market, 2018 - 2030 (USD Million)
- 6.3.4. Mexico
- 6.3.4.1. Key Country Dynamics
- 6.3.4.2. Competitive Scenario
- 6.3.4.3. Target Disease Prevalence
- 6.3.4.4. Mexico Biochip Market, 2018 - 2030 (USD Million)
- 6.4. Europe
- 6.4.1. Europe Biochip Market, 2018 - 2030 (USD Million)
- 6.4.2. UK
- 6.4.2.1. Key Country Dynamics
- 6.4.2.2. Competitive Scenario
- 6.4.2.3. Target Disease Prevalence
- 6.4.2.4. UK Biochip Market, 2018 - 2030 (USD Million)
- 6.4.3. Germany
- 6.4.3.1. Key Country Dynamics
- 6.4.3.2. Competitive Scenario
- 6.4.3.3. Target Disease Prevalence
- 6.4.3.4. Germany Biochip Market, 2018 - 2030 (USD Million)
- 6.4.4. France
- 6.4.4.1. Key Country Dynamics
- 6.4.4.2. Competitive Scenario
- 6.4.4.3. Target Disease Prevalence
- 6.4.4.4. France Biochip Market, 2018 - 2030 (USD Million)
- 6.4.5. Italy
- 6.4.5.1. Key Country Dynamics
- 6.4.5.2. Competitive Scenario
- 6.4.5.3. Target Disease Prevalence
- 6.4.5.4. Italy Biochip Market, 2018 - 2030 (USD Million)
- 6.4.6. Spain
- 6.4.6.1. Key Country Dynamics
- 6.4.6.2. Competitive Scenario
- 6.4.6.3. Target Disease Prevalence
- 6.4.6.4. Spain Biochip Market, 2018 - 2030 (USD Million)
- 6.4.7. Denmark
- 6.4.7.1. Key Country Dynamics
- 6.4.7.2. Competitive Scenario
- 6.4.7.3. Denmark Biochip Market, 2018 - 2030 (USD Million)
- 6.4.8. Sweden
- 6.4.8.1. Key Country Dynamics
- 6.4.8.2. Competitive Scenario
- 6.4.8.3. Target Disease Prevalence
- 6.4.8.4. Sweden Biochip Market, 2018 - 2030 (USD Million)
- 6.4.9. Norway
- 6.4.9.1. Key Country Dynamics
- 6.4.9.2. Competitive Scenario
- 6.4.9.3. Target Disease Prevalence
- 6.4.9.4. Norway Biochip Market, 2018 - 2030 (USD Million)
- 6.5. Asia Pacific
- 6.5.1. Asia Pacific Biochip Market, 2018 - 2030 (USD Million)
- 6.5.2. Japan
- 6.5.2.1. Key Country Dynamics
- 6.5.2.2. Competitive Scenario
- 6.5.2.3. Japan Biochip Market, 2018 - 2030 (USD Million)
- 6.5.3. China
- 6.5.3.1. Key Country Dynamics
- 6.5.3.2. Competitive Scenario
- 6.5.3.3. China Biochip Market, 2018 - 2030 (USD Million)
- 6.5.4. India
- 6.5.4.1. Key Country Dynamics
- 6.5.4.2. Competitive Scenario
- 6.5.4.3. Target Disease Prevalence
- 6.5.4.4. India Biochip Market, 2018 - 2030 (USD Million)
- 6.5.5. Australia
- 6.5.5.1. Key Country Dynamics
- 6.5.5.2. Competitive Scenario
- 6.5.5.3. Target Disease Prevalence
- 6.5.5.4. Australia Biochip Market, 2018 - 2030 (USD Million)
- 6.5.6. Thailand
- 6.5.6.1. Key Country Dynamics
- 6.5.6.2. Competitive Scenario
- 6.5.6.3. Target Disease Prevalence
- 6.5.6.4. Thailand Biochip Market, 2018 - 2030 (USD Million)
- 6.5.7. South Korea
- 6.5.7.1. Key Country Dynamics
- 6.5.7.2. Competitive Scenario
- 6.5.7.3. Target Disease Prevalence
- 6.5.7.4. South Korea Biochip Market, 2018 - 2030 (USD Million)
- 6.6. Latin America
- 6.6.1. Latin America Biochip Market, 2018 - 2030 (USD Million)
- 6.6.2. Brazil
- 6.6.2.1. Key Country Dynamics
- 6.6.2.2. Competitive Scenario
- 6.6.2.3. Target Disease Prevalence
- 6.6.2.4. Brazil Biochip Market, 2018 - 2030 (USD Million)
- 6.6.3. Argentina
- 6.6.3.1. Key Country Dynamics
- 6.6.3.2. Competitive Scenario
- 6.6.3.3. Target Disease Prevalence
- 6.6.3.4. Argentina Biochip Market, 2018 - 2030 (USD Million)
- 6.7. MEA
- 6.7.1. MEA Biochip Market, 2018 - 2030 (USD Million)
- 6.7.2. South Africa
- 6.7.2.1. Key Country Dynamics
- 6.7.2.2. Competitive Scenario
- 6.7.2.3. Target Disease Prevalence
- 6.7.2.4. South Africa Biochip Market, 2018 - 2030 (USD Million)
- 6.7.3. Saudi Arabia
- 6.7.3.1. Key Country Dynamics
- 6.7.3.2. Competitive Scenario
- 6.7.3.3. Target Disease Prevalence
- 6.7.3.4. Saudi Arabia Biochip Market, 2018 - 2030 (USD Million)
- 6.7.4. UAE
- 6.7.4.1. Key Country Dynamics
- 6.7.4.2. Competitive Scenario
- 6.7.4.3. Target Disease Prevalence
- 6.7.4.4. UAE Biochip Market, 2018 - 2030 (USD Million)
- 6.7.5. Kuwait
- 6.7.5.1. Key Country Dynamics
- 6.7.5.2. Competitive Scenario
- 6.7.5.3. Target Disease Prevalence
- 6.7.5.4. Kuwait Biochip Market, 2018 - 2030 (USD Million)
- Chapter 7. Competitive Landscape
- 7.1. Company Categorization
- 7.2. Strategy Mapping
- 7.3. Company Market Position Analysis, 2024
- 7.4. Company Profiles/Listing
- 7.4.1. Agilent Technologies
- 7.4.1.1. Overview
- 7.4.1.2. Financial Performance
- 7.4.1.3. Product Benchmarking
- 7.4.1.4. Strategic Initiatives
- 7.4.2. PerkinElmer, Inc.
- 7.4.2.1. Overview
- 7.4.2.2. Financial Performance
- 7.4.2.3. Product Benchmarking
- 7.4.2.4. Strategic Initiatives
- 7.4.3. Illumina, Inc.
- 7.4.3.1. Overview
- 7.4.3.2. Financial Performance
- 7.4.3.3. Product Benchmarking
- 7.4.3.4. Strategic Initiatives
- 7.4.4. Bio-Rad Laboratories, Inc.
- 7.4.4.1. Overview
- 7.4.4.2. Financial Performance
- 7.4.4.3. Product Benchmarking
- 7.4.4.4. Strategic Initiatives
- 7.4.5. Standard BioTools Inc.
- 7.4.5.1. Overview
- 7.4.5.2. Financial Performance
- 7.4.5.3. Product Benchmarking
- 7.4.5.4. Strategic Initiatives
- 7.4.6. GE HealthCare
- 7.4.6.1. Overview
- 7.4.6.2. Financial Performance
- 7.4.6.3. Product Benchmarking
- 7.4.6.4. Strategic Initiatives
- 7.4.7. IBIOCHIPS
- 7.4.7.1. Overview
- 7.4.7.2. Financial Performance
- 7.4.7.3. Product Benchmarking
- 7.4.7.4. Strategic Initiatives
- 7.4.8. LI-COR, Inc.
- 7.4.8.1. Overview
- 7.4.8.2. Financial Performance
- 7.4.8.3. Product Benchmarking
- 7.4.8.4. Strategic Initiatives
- 7.4.9. Cellix Ltd
- 7.4.9.1. Overview
- 7.4.9.2. Financial Performance
- 7.4.9.3. Product Benchmarking
- 7.4.9.4. Strategic Initiatives
- 7.4.10. Randox Laboratories Ltd.
- 7.4.10.1. Overview
- 7.4.10.2. Financial Performance
- 7.4.10.3. Product Benchmarking
- 7.4.10.4. Strategic Initiatives
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook